GLG News by ArteFill Users
Request a free trial
April 23, 2007Altabax will have good sales in the impetigo market
Analysis of: FDA Approves Antibiotic Ointment For Children And Adults - Altabax (retapamulin Ointment) | www.medicalnewstoday.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Altabax (retapamulin) will be a competitive topical agent for impetigo because it is a new molecular entity, Bactroban or mupirocin is generic and cannot compete directly, and it is indicated for children as young as 9 months. The market for a nonoral antibiotic is always good, due to lower side ef...
April 23, 2007ELEVESS gets CE mark approval
Analysis of: Anika Gets CE Mark Certification For Commercial Sale Of Cosmetic Dermatology Product, ELEVESS In European Union | www.tradingmarkets.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
ELEVESS received its CE mark approval in Europe. The product is entering a crowded field with no real differentiating factors other than having lidocaine as an anesthetic. To release this product in the US without a partnership with an established company will be very hard. It will not be easy to compete...
April 9, 2007
good from afar, far from good
Analysis of: Sculptra(TM), new cosmetic dermatology treatment, creates long-lasting, natural-looking results | www.newswire.ca
Author: GLG Expert Contributor
Analysis of: Sculptra(TM), new cosmetic dermatology treatment, creates long-lasting, natural-looking results | www.newswire.ca
Author: GLG Expert Contributor
Sculptra, although a good option for fat loss in the face, the claimed advantages by the release actually contradict themselves within the release itself. It still requires a number of injections, just like the other fillers they condemn. Also it is made for deep injections and the incidence of...
April 9, 2007
far from new, except the wavelength
Analysis of: Cutera Receives FDA Clearance For Its New Laser, Pearl, Using YSGG Technology | www.medicalnewstoday.com
Author: GLG Expert Contributor
Analysis of: Cutera Receives FDA Clearance For Its New Laser, Pearl, Using YSGG Technology | www.medicalnewstoday.com
Author: GLG Expert Contributor
a new wavelength utilized is the only new aspect of this. Other wavelengths and lasers have been used for over 10 years that can do the same thing. Another example of a company that came out with big claims for its non-invasive technology and got tired of patients and doctors complaining of lack of...
April 4, 2007Collagenex Incyclinide phase 2 data released
Analysis of: CollaGenex Pharmaceuticals Announces Positive Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Acne | www.pipelinereview.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
The phase 2 data for Incyclinide indicate a modest benefit over placebo for the 20 mg dose only, which drops off at 12 weeks. This drug will need a higher dose for efficacy. The premise behind a non antimicrobial antibiotic type medication is valid and intriguing. The next trial results are important...
March 29, 2007
melt away your disappointments
Analysis of: Cosmetic surgeons aim lasers to melt away fat | www.bucyrustelegraphforum.com
Author: GLG Expert Contributor
Analysis of: Cosmetic surgeons aim lasers to melt away fat | www.bucyrustelegraphforum.com
Author: GLG Expert Contributor
nice to feed off people's fears and desires, but it is no better than what has been out there for years and the claims made do not hold up, I have had many patients say it hurt, it did not allow them to return to work in the time stated and the results are not as dramatic as they were told they would...
March 26, 2007
lifting boomers
Analysis of: Cosmetic Plastic Surgery for Baby Boomers Shifts to Lifts | www.plasticsurgery.org
Author: GLG Expert Contributor
Analysis of: Cosmetic Plastic Surgery for Baby Boomers Shifts to Lifts | www.plasticsurgery.org
Author: GLG Expert Contributor
expected as the baby boomers are living active lives and since they are older to begin with, lesser minimally invasive techniques will not give them the desired changes. Also since they are retiring or have already retired, they can hibernate during the recovery period more easily, allowing them to...
March 26, 2007
Men want it too
Analysis of: Men Fill Face, Modify Midsection with Cosmetic Plastic Surgery | www.plasticsurgery.org
Author: GLG Expert Contributor
Analysis of: Men Fill Face, Modify Midsection with Cosmetic Plastic Surgery | www.plasticsurgery.org
Author: GLG Expert Contributor
shows the increasing desire of men for cosmetic enhancement, they desire less obvious facial changes with less down time as it is hard to hide stigma of facial surgery due to no make up but can have body procedures as they are easy to hide and will eventually yield a youthful toned body. They want it...
March 26, 2007
Mommy Makeover comments
Analysis of: Cosmetic Plastic Surgery "Mommy Makeovers" on the Rise | www.plasticsurgery.org
Author: GLG Expert Contributor
Analysis of: Cosmetic Plastic Surgery "Mommy Makeovers" on the Rise | www.plasticsurgery.org
Author: GLG Expert Contributor
quite factual and understandable. As patients get older their surgical needs grow and since pregnancy affects multiple areas on women's bodies, these multiple procedures are more desired and since anesthesia techniques ar safer, there is a greater tendency to combine multiple procedures together to...
March 23, 2007Gadolinium agents linked to NFD
Analysis of: Nephrogenic Fibrosing Dermopathy Associated with Exposure to Gadolinium-Containing Contrast Agents | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This and other studies are highly suggestive that Gadolinium agents used in radiographic studies are associated with NFD. A large scale study should be initiated to confirm this association, and for now these agents should be avoided in patients with renal disease.
Previous Page : 1 2 3 4 5 6 7 8 9 Next51 to 60 of 82
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Use of Antipsychotics in Children Is Criticized
www.nytimes.com
Scientists recommend 'black box' for Avastin
www.fiercepharma.com
Are Costly Diabetes Pills Doing Any Good?
www.pharmalot.com
How a Drug Maker Tries to Outwit Generics
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

